HDAC4 and juvenile Huntington disease: HDAC4 inhibition has demonstrated significant effects to increase the stability of MAP1S, MAP1S-mediated autophagy flux and degradation of mutant Huntingtin aggregates that are directly impact Huntington's disease [33].